GB2603634A - Flower essence-containing medicaments - Google Patents

Flower essence-containing medicaments Download PDF

Info

Publication number
GB2603634A
GB2603634A GB2118418.9A GB202118418A GB2603634A GB 2603634 A GB2603634 A GB 2603634A GB 202118418 A GB202118418 A GB 202118418A GB 2603634 A GB2603634 A GB 2603634A
Authority
GB
United Kingdom
Prior art keywords
volume
rosa
composition according
composition
essences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB2118418.9A
Other versions
GB2603634B (en
Inventor
G Harvey Clare
Naerbo Dori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Floweressence Cgh Ltd
Original Assignee
Floweressence Cgh Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Floweressence Cgh Ltd filed Critical Floweressence Cgh Ltd
Publication of GB2603634A publication Critical patent/GB2603634A/en
Application granted granted Critical
Publication of GB2603634B publication Critical patent/GB2603634B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

A composition suitable for reducing or alleviating stress, comprising one or more plant stem cell extracts (apical shoots, cambium, root apical meristems) and one or more flower essences. The stem cells may be from monocot and dicot flowering plants, shrubs, trees. The flower essences may be from the flowers as defined herein, which may be from 0.1-15% by volume. The composition may comprise one or more secondary flower essences, as defined herein, which may be from 0.5-15% by volume. The composition may comprise one or more essential oils, as defined herein, which may be from 0.05-5% by volume. The composition may be an aqueous-based extract, or may be a cream. The composition may comprise one or more berry extracts, which may be maiqui berries. The composition may comprise Fitzroya cupressoide. The flower essences may be from the traditional Bach method in which flowers are floated in a crystal bowl and left in sunlight for up to 2-3 hours, mixing with an equal volume of alcohol or red shiso. Example formulations comprising orchid (Orchidaceae) essences are given. Phytolaits may be used to form a base cream. The composition may be a topical cream, and may be a body oil.

Description

FLOWER ESSENCE-CONTAINING MEDICAMENTS
This invention relates to the use of flower essence-containing medicaments, particularly those that are useful for the alleviation of stress. More particularly, though not exclusively, the invention relates to topical applications including creams, such as facial and body cream, oils, spritzers and toners and serums, for oral and/or external application, that are useful for the alleviation of stress.
BACKGROUND TO THE INVENTION
"Stress" is defined to be any interference that disturbs a person's healthy mental and physical well-being. Our stress response is relative and highly individual. Stress is being recognized as a medical condition. Scientists at Harvard University researching into the effect of stress on the body have discovered shared interactive chemicals and links between the mind and the body, especially in relation to the nervous system, immune and endocrine system as well as the skin. In fact, stress has been dubbed the -Health Epidemic of the 21st Century" by the World Health Organization. According to the Centers for Disease Control and Prevention, stress-related disorders and diseases such as heart disease, obesity and diabetes have been on the rise in the whole population for decades. A similar pattern is emerging in stress-related mental health. Studies and research show, that the vast majority of people are feeling stressed, anxious and overwhelmed. Chronic stress has become the new-norm reaching epidemic proportions. And it shows up in our bodies, even before we get sick. Even though we're more connected than ever before, loneliness is now considered a major stress factor.
Stress raises your cortisol levels. Researchers have known for years that elevated cortisol levels sustained over time causes damage. Examples of the damaging effects of chronic stress in the brain include: free radicals harming brain cells; making a person become more forgetful and emotional; creating a vicious cycle of fear and anxiety; halting the production of new brain cells; depleting critical brain chemicals causing depression; increasing risk for mental illnesses of all kinds; shrinking your brain; allowing toxins into your brain; increasing your risk of dementia and Alzheimer's; promoting brain cells to commit suicide; and chronic stress contributing to brain inflammation and depression. Examples of physical effects as a result of chronic stress in the brain include: lowering your immune system; weight gain; increased blood pressure; lowering bone density; high cholesterol; increased risk of heart disease; erectile dysfunction; increased risk of heart attack; low sex drive; headaches; insomnia; and digestive problems.
A person may experience stress in response to a wide range of physical and emotional stimuli, including physical violence, internal conflicts and significant life events such as death of a loved one, birth of a baby, or divorce. Some people are more susceptible than others to stress-related medical problems. When faced with a stressful situation the body responds by increasing production of certain hormones such as cortisol and adrenaline. These hormones lead to changes in heart rate, blood pressure, metabolism, and physical activity designed to improve overall performance. However, at a certain level, they disrupt an individual's ability to cope. Continued exposure to stress often leads to mental and physical symptoms, such as anxiety and depression, indigestion, palpitations, low libido, insomnia, weight gain or loss, and muscular aches and pains.
It is now accepted and recognized that there is a direct correlation between the mind, and the body. Whether positive or negative, stress has a direct beneficial or detrimental effect on the physiology of the body.
Various treatments are used to assist people suffering from stress, including pharmaceutical drug therapy, complementary medicine, relaxation techniques such as yoga and meditation, aromatherapy and other therapeutic modalities.
Aromatherapy involves a range of treatments using essential oils and flower essences that are extracted from plants. Essential oils are known to contain the plant actives that have a beneficial effect of repairing the cellular structure of the skin and helping to stimulate the growth of new cells; flower essences, on the other hand, are known as the flowers liquid energy and have the extraordinary ability directly to enhance and alter our emotional response to ourselves and the world, bringing relief from unsettling moods and emotions such as fear, anxiety, guilt, anger and melancholy, and helping with the development of a positive and stress-free attitude towards our life. It is well known that a happy self-image has a powerful physiological effect that adds to the inner glow of health vitality. Many ancient civilizations, particularly the Chinese, documented the use of such materials in treating different disorders, and some aromatherapy treatments are known to have effect on stress-related conditions. Indeed, the Australian Aborigines practiced one of the most ancient forms of flower essence therapy. Around 10,000 years ago they were gathering dew-drenched flowers and either drinking the dew or placing the flowers in their mouths. If the flowers were inedible, then they would simply sit among them. They found that the flowers could restore a person's mental attitude. If someone were afraid, they would gain courage, if angry they would find peace, if sick would become well again. It is believed that Native Americans, Minoans and ancient Egyptians harnessed the healing powers of flowers in similar ways.
Whilst the aforementioned flower essences are well established, such as disclosed in GB2409645B by the same inventor, the field of alternative (complimentary) therapies continues to advance and stem cell properties have come to the fore is also being beneficial.
Stem cells are used in regenerative medicine and as a source of undifferentiated cellular material provide the opportunity for rebuilding tissues as the stem cells as the stem cells differentiate and can be incorporated into the tissue thus regenerating it. "Anti-Aging Properties of Plena Stem Cell Extracts" to Miastkowska, M. eta/in Cosmetics (2018), Vol.5, No.55 discloses skin aging is a complex process which involves all the layers of the epidermis and dermis. Plant stem cells show outstanding anti-aging properties, as they can, among other activities, stimulate fibroblasts to synthesise collagen, which, in turn, stimulates skin regeneration. One of the most important agents which give anti-aging properties to plant stem cell extracts is kinetin (6-finfuryladenine). It enables cells to remove the excess of free radicals to protect them from oxidative stress. "Plant stem cells' in cosmetics: current trends and future directions" to Trehan, S. eta/in Future Sci OA. (2017) Vol.3, No.4, discloses that plant regeneration at the cellular and tissue level is a unique process, and that the stem cells in plants have properties that help stimulate and regenerate plants after injury. "WoutidHealing Effects of Rose Placenta in a Mouse Model of Full-Thickness Wounds" to Kim, Y.W. eta/in Arch Plast Surg. (2015), Vol.42, No.6, pp.686-694, discloses Rosa damascena, a type of herb, which has been used for wound healing in Eastern folk medicine, and which was used to evaluate the effectiveness of rose placenta in a full-thickness wound model in mice. "Stem hark andfirmer extracts of Vismia cauliflora: modulation of oxidative burst in human nezitrophils' and inhibition of oxidative damage in human erythrocytes" to Ribeiro, A.B. et al in Free Radical Biology and Medicine (2014), Vol.75, Supp.1, pp.S45-S46, discloses Vismia cauliflora, an Amazonian plant traditionally used to treat dermatosis and inflammatory processes of the skin by indigenous populations.
As will be appreciated, whatever the specific mechanism of action whether in alternative therapies or classical medicine there are perceived benefits in providing compositions containing components which provide beneficial effects, whether through a physiological mechanism or a psychological mechanism. There is therefore a need to provide compositions suitable for delivery to the human body comprising the aforementioned ingredients. The provision of such compositions which are physiologically acceptable, have physical properties to enable them to be readily delivered to a point of use, and are physically, chemically and biologically stable is therefore advantageous. Each one of these individual properties is in itself advantageous.
A specific form of plant of interest in providing plant-based remedies are orchids. There are many hundreds of varieties of orchids indigenous to many countries or regions of the world. Some orchid essences, such as Caladenia latifolia, Chytroglossa entrata and Hofmeister eliciru microscopica, are known to reduce stress levels when administered orally or topically.
SUMMARY OF THE INVENTION
The invention relates to a topical-application composition suitable for reducing or alleviating stress, the composition comprising one or more plant stem cell extracts in combination with one or more flower essences.
Preferably the one or more plant stem cell extracts are selected from all monocot and dicot flowering plants, shrubs and trees.
Preferably the one or more flower essences are selected from essences, such as Ac/newt superba, Amazonas, Angulo aclowesii, Caladenia latifidia,Cattleyawarscewiczn, Cattleyatrianae, Chytroglossa aura/a, Cymbidium lowianum, Epidendrum chioneum, Epidendrum prismatocatpum, Epidendrum sectmdum, Fitzroya cupressoide, Holmeister charm microscopica, Laeliocattleya anceps clara, Lae liocattleya hybr., Itonia phalaenopsis, 017d(111M7 abortivum, Oncidium ahissi mum, °tic id/um incur rum, °medium lanceamtm, Oncidium sphacelatum, Orchis mascida, Paphiopedihtm harrysianum, Paphiopedilum insigne, Stanhopeawardii, Vanda tricolor, Victoria amazon/ca and combinations thereof One particular flower essence species of interest is Fitzroya cupressoide belonging to the Cupresaceae family. It is a monotypic genus, known as Alerce or Patagonian Alerce native to Argentina and Chile. It is a slow growing species, and it has been reported that a specimen over 3600 years has been found in the Alerce Coastal National Park in Chile.
Few studies on the physiology or metabolism of Fitzroya cupressoides have been made. "Sesquiterpene alcohols from Ibliage of Fitzroya cupressoicles" to Cool, L.G in Phytochemistry (1996), Volume 42, No.4, pp.1015-1019 discloses a new trans-fused himachal-4-en-1-ol which was isolated from the foliage of the a-longipinene-producing chemotype of Fitzroy.' cupressoides, and characterized by 1D-and 2D-NMR by partial synthesis. 1JS5955621 discloses Alerce seed and sprout cells which were used to evaluate the presence of taxane compounds (for antineoplastic uses) in plant cells.
An aqueous extract obtained from Alerce cells, having pharmaceutical and cosmetic properties, particularly in skin regeneration and anti-aging effect is known (W02020/075074A1). The extract is useful in developing products for the treatment and protection of the skin in order to promote health, and reduce the appearance of wrinkles and expression lines, as well as tissue regeneration in cases of recent injury or scarring.
It has now been surprisingly discovered that extracts of Filzroya cupressoides essences can be used in the preparation of medicaments for reducing stress levels.
Most preferably, the one or more flower essences are selected from Amazonas, Angulo aclowesii, Ccdadenia Cattleya warscew iczii, Chytroglossa aura/a, Epidendrum chioneutn, Epidendrum secundum, Fitzroya cupressoide, Hoftneister alarm microscopica, Alittonia phalaenopsis, Oncidium ahortivum Oncidium,sphace!alum and combinations thereof Preferably the composition is an aqueous-based extract.
Preferably the composition is a cream.
Preferably the composition includes one or more optional berry extracts including, but not limited to, extracts of Maiqui berries.
The addition and inclusion of all monocot and dicot flowering plants, shrubs and trees, and their stem cells essence is envisaged. During the creation process of stem cell essence, naturally occurring stem cells may be present. Their robust mechanism for regeneration of tissue under stress, to the existing patent invention, expands and enhances the therapeutic action and value of all the medicament applications previously mentioned.
Plant stem cells are the very essence of the food we consume, air we breathe and fuel we burn. Hence, plant stem cells may be an important source to maintain homeostasis and optimum health. According to Current Biology, (Greb & Lohmann 2016) "In some long-lived plants, such as trees, plant.s/em cells remain active over hundreds' or even thousands of years, revealing the exquisite precision in the underlying control ofproliferation"selfrenewal and differentiation." Plant stem cells are located in three places: 1) apical shoots of monocot and dicot flower plants, shrubs and trees which are located at just below the flowering shoot(s), 2) cambium of monocot and dicot flower plants, shrubs and trees which are located in the stems of flowering shoots, and 3) root apical meristems of monocot and dicot flower plants, shrubs and trees which are located in the roots of the flowering shoots.
The unique properties of plant stem cells have been a recent area of interest and focus both in developing new cosmetics. Every organism has stem cells and plant stem cells come from the stem of the plant. Plant regeneration at the cellular and tissue level is a unique process and the stem cells in plants have properties that help stimulate and regenerate themselves after injury. Plants are equipped with a robust mechanism for regeneration of their tissues under stress.
One of the ways to extract the stem cells is the plant is allowed to dry in order to activate the stem cells as this is the point that the plant produces more stem cells to heal itself another method is to bruise or cut the root and allow the natural process of osmosis to occur, using the sun method of preparation. The process of osmosis is the dispersal of solvent molecules across a selectively or semi-permeable membrane where the molecules move from a higher concentrated solution to more dilute solutions. Where in this case this form of extraction can be enhanced by the presence of warmth of direct sun light. Cell division in plants occurs in regions called meristems. Cells of the meristem can differentiate to produce all types of plant cells at any time during the life of the plant. The main meri-stems are close to the tip of the shoot, and the tip of the root.
In a growing shoot, new cells are being produced continuously near the tip. As the cells become older, they move further away from the tip and become differentiated Plant stem cells show outstanding anti-aging properties, as they can, among other activities, stimulate fibroblasts to synthesise collagen, which, in turn, stimulates skin regeneration. Skin aging is a complex process which involves all the layers of the epidermis and dermis. In order to slow skin aging, methods are researched which would strengthen and protect skin stem cells.
Science is in search of the right method to stimulate the proliferation of epidermal stem cells. One of the most important agents which give anti-aging properties to plant stem cell extracts is kinetin (6-furfuryladenine).
Kinetin (6-furfuryladenine) This compound belongs to a cytokine group and is considered to be a strong antioxidant which protects protein and nucleic acids from oxidation and glycoxidation processes. It enables cells to remove the excess of free radicals to protect them from oxidative stress and all forms of skin stress in general.
Stem cell essences and stem cells of monocot and dicot flower plants, shrubs and trees are contained within the flower essence, which are an essential component. Part of the process of extracting the essences involve a simultaneous process of extracting the stem cells creating a symbiotic process.
Accordingly, the present invention provides the use of one or more essences in the preparation of medicaments for reducing stress levels. In another aspect, there is provided a medicament for use in topical applications including creams, such as facial and body cream, oils, spritzers and toners and serums, for oral and/or external application to the face, body, hair, eyebrows and eyelashes, that are useful for the alleviation of stress. All forms of cosmetics designed for men and woman are contemplated including, but not limited to, nail polish, eye shadows, lipsticks, foundation, blushes, powder essence, bronzer, highlighters and mascara, comprising one or more orchid essences, in addition to, precious metals, precious and semi-precious stones, crystals, gems in solution, powder, elixir and essence.
Medicaments comprising one or more specific essences have strong mood enhancing properties and are thereby extremely effective at reducing stress levels in the human body. These highly beneficial properties of these specific orchid essences were hitherto unknown.
Applications of the invention can include one or more of the following features: The medicaments can further include a flower remedy liquid essence, tincture, oral spray and body spritzers. These flower essence solutions can reduce stress and promote a sense of emotional and psychological well-being. When the medicaments measured by heart rate variability can demonstrate a reduction in biological age in comparison to chronological age.
The flower essence solutions can include a member selected from the group consisting of flower essences, adaptogens, polyphenols, antioxidants, herbal extract, vitamin, crystal essence, precious, semi-precious gems, and precious metal essences, mineral, herb, and combinations thereof The medicaments reduce stress, anxiety and enhance mood. As a result, it may improve sleep and accelerate skin repair, cellular regeneration, improve collagen, hair and nail growth.
The medicaments may optionally comprise one or more further non-orchid flower essences (hereafter termed "secondary flower essences") one or more essential oils, one or more phytolaits, one or more whole perennial and annual plants, cereal grains, deciduous and evergreen in its entity including the seeds, roots, root apices, stems, leaves, meristems, apical shoots, and complete flowers, one or more of the proteaceae family, one or more of the coniferophyta family, one or more of the rosaceae family, one or more of the anthophyta family, one or more phytocermides, one or more peptides, one or more plant stem cells, one or more plant stem cell signaling peptides, one or more berries, one or more seed oils, one or more fruit cell extracts and fruit oils, one or more flower extracts, one or more leaf extract, one or plant stem cells extracts, one or more hydrolat flower waters, one or more tea extracts, one or more adaptogenic herbs, one or more of the algae family, one or more mushrooms, e.g. tremella, chaga, reishi, shiitake, and one or more monoils.
In each of the above aspects, the essences are selected from Acinetasuperba, Amazonas', Epidendrum secundum, Miltonia phalaenopsis, Oncidium incurvum, Stanhopeawardii, Oncidium lanceanum, Cymbidium lowianum, Epidendrum prismatoccupum, Cattleya warscewiczn, Vanda tricolor, Lae liocattleya hybr., Lae liocattleya cmceps clara, Cauleyatriattae, ()medium abort/rum, Paphiopedilum hart:y.50mm, Paphiopediluminsigne, Epidendrumchioneum, Angulo ado 14 Orchismascula, Oncidium sphacelautm and Victoria amazon/ca. Preferred orchid essences are selected from Epidendrum secundum, 15 Miltonia phalaettopsis, Epidendrum chioneum, Angulo ac/owes;,, Oncidium sphacelatum, Amazonas, Cattleya warscewiczn and Oncidium (Marilynn).
The secondary flower essences are selected from Aesculus hippocastanum, Bromus ramosus, Rosa canina, Salix vitellina, RQ5 (Cherry plum, clematis, impatiens, Rock rose and Star of 20 Bethlehem) and RQ8 (Cherry plum, clematis, impatiens, Rock rose, Star of Bethlehem Lotus and Self-heal); essences from cacti and succulent plants such as: Caralhtma russelliana, Cerezts peruvicums, Ceropegia Cleistocactu,5 ritterei, Cleistocactzts Echinocactus grusonii, Echirtocerems scheeri, Eche nopsi5 oxygona, Ferocactus schwarzii, Hylocereus mutants, Alammillaria rubrograndis, Alyitillocactus geometrizans, Opuntia cardiosperma, Opuntia dejecta, Orbea variegata, Pilosocereus pachycladus"Selenicereus grandiflorus, Seticereus icosagomts, Stenoceretts marginatus and Stopelia desmetictna; rose essences such as Rosa roxbourghii, Rosa majalis, Rosa,spinosissima, Rosa x pruhoniciana, Rosa rttgosa "Sara van fleet", Rosa rugosa "Souvenir de philemoncochet", Rosa Aloyesi; essences from Africa and the Canary islands such as Ant:wills ctrvensis, Musa x paradisiacal "nanct, Erica arborea, Plumbago auriculata, Eucalyptus globules, Monstera deliciosa, Sonchus acaulis, Geranium perforatum, K9,Canarina canctriensis, Artemisia arvensis, Cocos nucifera, Mimosa pudica, Echi um vulgare, Strelitziareginae, Narcissus tazettct, Hibiscus ro,5a SillellS1S, Echium wildpretii, Euphorbia pulcherrima and Cistus albidus; and wild flower essences such as Aloe vera, Arnica montana, °chum basi Ileum, Borago officinal's, Prunella vulgarly, Ranunculus acris, germanica, Hyper/cum pedbratum, Verbascum thapsus, Lavandula officinalis, Taraxacu officinale, Viscum album, Rosmarinus officinalis, Trifb pratense, Achillea male/61nm', He//ant/ins (111111111S, Dicentra,spectabilis, Viola hirta, Myosotis sylvatica, Zinnia (legal's, Valerian() officinalis, Rubus fructicosus, Zantedeschia aethiopica, Anethum graveolens Lethal, buffiferum, Belles perennis, Matricaria chamomilla, Polygonum Instorta, Cucurbita pepo, Nelumbo nucifera, Prunus amygdalus, Zen mays, Pass/flora bryonioides, Ipomea pzirpurea, millelblium, Salvia qt./lc:Eu(0s, Epilobium angustifithum, Paradisea Allem angulosum, Daucus carota, Opuntia cardiospera, Seticereus icosagonus, Stapelia deshietiana, Rosa, Chinensis viridijlora, Ginkgo biloba, Citrus limon, Geranium pelf' bratum, Cananna ccmanersis, Narasszistuzetta, Hibiscus rosa-sinensis, Ostia Achillea milleaum, Salvia o Vinca minor, Echinaecea pzupurea, Jepunbali, Jepunjawa, Aloe striata, All/m?' ursinum, lUssilago.farara, Oenothera lentils Capsicum ammum, Celendula officinally, Mentha pulegium and Primula veris.
The preferred secondary flower essences are selected from Rosa amino, Echinocereus scheeri, Pilosocereus pachycladus, Rosa x pruhonicicma, Rosa Moyesii, Canarienyis, Strelitzia reginae, Aloe vera, Arnica montana, Prune/la vulgarly, Zinnia elegans, Matricaria chamomilla, Nelumbo nucifera, Pass/flora bryonioides, Paradisea Illiastmin, Rosa spinosissima, Hibiscus Rosa, Jepunbali, Jepunjawa, Rosa roxbourghii, Orbea variegata, Cocos micifera, Opuntia cardiosperma and Diann bulbiferum.
Suitable essential oils include those from: Citrus reticulata, Chamaemelum, Geraniaceae such as Pelargonium gravea, Aurantium Bergamia, Lavandula angustifinlia, Rosa centifloria absolute"layminum officinale abs, Citrus paradisi, Cananga odorata, Buswellia sp., aurantifblia, riganum, Citrus aurantium, Cymbopogan martini, Ravensara aromatica, SunOS; album, San/alum vicuna)", Lavendula x intermedia, Cymbopogon citrates, Citrus reticulata, Melissa officinally and Citrus sinesnsis.
Preferably, the amount of the one or more flower essences is present in an amount of at least at least 0.1% by volume, preferably at least 0.2% by volume, preferably at least 0.3% by volume, preferably at least 0.4% by volume, preferably at least 0.5% by volume, preferably at least 0.6% by volume, preferably at least 0.7% by volume, preferably at least 0.8% by volume, preferably at least 0.9% by volume or preferably at least 1.0% by volume.
Preferably, the amount of the one or more flower essences is present in an amount of at most 9% by volume, preferably at most 9.5% by volume, preferably at most 10% by volume, preferably at most 10.5% by volume, preferably at most 11% by volume, preferably at most 11.5% by volume, preferably at most 12% by volume, preferably at most 12.5% by volume, preferably at most 13% by volume, preferably at most 13.5% by volume, preferably at most 14% by volume, preferably at most 14.5% by volume, preferably at most 15% by volume, preferably at most 15.5% by volume, preferably at most 16% by volume, preferably at most 16.5% by volume, preferably at most 17% by volume, preferably at most 17.5% by volume, preferably at most 18% by volume, preferably at most 18.5% by volume, preferably at most 19% by volume, preferably at most 19.5% by volume or preferably at most 20% by volume.
More preferably, the amount of the one or more flower essences is present in the range 0.515% by volume. Most preferably, the amount of the one or more flower essences is present in the range 2-10% by volume.
Preferably, the amount of the one or more secondary flower essences is present in an amount of at least at least 0.1% by volume, preferably at least 0.2% by volume, preferably at least 0.3% by volume, preferably at least 0.4% by volume, preferably at least 0.5% by volume, preferably at least 0.6% by volume, preferably at least 0.7% by volume, preferably at least 0.8% by volume, preferably at least 0.9% by volume or preferably at least 1.0% by volume. Preferably, the amount of the one or more secondary flower essences is present in an amount of at most 9% by volume, preferably at most 9.5% by volume, preferably at most 10% by volume, preferably at most 10.5% by volume, preferably at most 11% by volume, preferably at most 11.5% by volume, preferably at most 12% by volume, preferably at most 12.5% by volume, preferably at most 13% by volume, preferably at most 13.5% by volume, preferably at most 14% by volume, preferably at most 14.5% by volume, preferably at most 15% by volume, preferably at most 15.5% by volume, preferably at most 16% by volume, preferably at most 16.5% by volume, preferably at most 17% by volume, preferably at most 17.5% by volume, preferably at most 18% by volume, preferably at most 18.5% by volume, preferably at most 19% by volume, preferably at most 19.5% by volume or preferably at most 20% by volume. More preferably, the amount of the one or more secondary flower essences is present in the range 0.5-15% by volume. Most preferably, the amount of the one or more secondary flower essences is present in the range 2-10% by volume.
Preferably, the amount of the one or more essential oils is present in an amount of at least at least 0.01% by volume, preferably at least 0.02% by volume, preferably at least 0.03% by volume, preferably at least 0.04% by volume, preferably at least 0.05% by volume, preferably at least 0.06% by volume, preferably at least 0.07% by volume, preferably at least 0.08% by volume, preferably at least 0.09% by volume or preferably at least 0.1% by volume.
Preferably, the amount of the one or more essential oils is present in an amount of at most Pli'o by volume, preferably at most 1.5% by volume, preferably at most 2% by volume, preferably at most 2.5% by volume, preferably at most 3% by volume, preferably at most 3.5% by volume, preferably at most 4% by volume, preferably at most 4.5% by volume, preferably at most 5% by volume, preferably at most 5.5% by volume, preferably at most 6% by volume, preferably at most 6.5% by volume, preferably at most 7% by volume, preferably at most 7.5% by volume, preferably at most 8% by volume or preferably at most 8.5% by volume. More preferably, the amount of the one or more essential oils is present in the range 0.05-5% by volume. Most preferably, the amount of the one or more essential oils is present in the range 0.05-3% by volume. Highly preferably, the amount of the one or more essential oils is present in the range 0.1-1% by volume.
Phytolaits are plant milk that are rich in natural plant proteins, lipids and sugars. They are useful, particularly in cream formulations to be applied to the skin, because they have skin-hydrating, moistening and restructuring properties. Suitable phytolaits can be extracted from acacia flowers (Robinia pseudo-acacia), almonds, aloe vera, apricots, barley, blond pea, coconut, copalba, grape seeds, green tea, jasmine flowers, lotus flowers, lupine flowers, nectarines, oats, palms, passion flowers, soybeans and walnuts. Preferred phytolaits are extracted from acacia flowers and jasmine flowers.
The flower essences used in the present invention may be extracted from flowers using any known technique such as, for example, the traditional Bach method in which the flowers are floated in a crystal bowl and left in sunlight for up to 2-3 hours. Mixing with an equal volume of alcohol or red shiso, which then preserves the resulting mother tincture Alternatively, a crystal method may be used in which the blooms are neither picked nor damaged. A mother tincture is obtained which is again preserved with an equal volume of alcohol or red shiso. The alcoholic or red shiso mother tincture is then generally used directly or in a diluted stock form. The medicaments of the present invention may be taken internally or applied externally to the body. Externally, they may be used pure or, for example, in the form of a soapy or aqueous emulsion, in an alcoholic solution, in an oil base, as a liniment, in overall or localized bathing, and in the form of creams, balms, lotions and spritzers Internally, depending upon the case, dosage will vary between 5 and 20 drops of pure essence administered several times a day before or after meals, or between 20 and 30 drops of pure essence administered several times a day in water, under the tongue or directly on the wrist.
Preferably the medicament is in the form of a topical cream, such as a facial cream. Typically, the cream will comprise: one or more orchid flower essences, one or more secondary flower essences, one or more essential oils and one or more phytolaits.
The phytola ts are used to form a "base cream" and the flower essences, essential oils and any other ingredients are added to this. Fitzroya cupressoide (Alerce) may also be used as a base in a form of concentrated serum form for any formulation according to the invention. The amount of the one or more orchid flower essence is preferably in the range 0.5-15% by volume of the base cream, 1-15% by volume is highly beneficial and 2 -10% by volume is especially advantageous. These quantities are also typical for the amount of secondary flower essence used. The amounts of essential oil used are typical, such as from 0.05-5% by volume of the base cream, preferably 0.05-3% by volume and further preferably 0.1-1% by volume.
0.2% by volume is especially advantageous depending on the formulation requirements.
In an alternative embodiment, the medicament of the invention may also be formulated as a body oil in which the amount of phytolait is either reduced or replaced by one or more mono oils A preferred mono oil is Tahitian coconut oil Again, the flower essences and essential oils are added to the one or more mono oils in the same % by volume amounts described above.
Other ingredients may also be optionally included in the topical cream formulations, for example, manuka honey, herbal and floral waters, crystals and gems and precious and semi-precious metals such as gold and silver.
The present invention will now be described with reference to the following Examples.
Examples
Orchid flower essence-containing medicament Formulations 1-3 according to the present invention are detailed below. Formulations 1-3 are the basis for the spritzers and toners.
These were made using conventional methods, which involve firstly forming a base cream from phytolait and then drop wise addition of the flower essences and essential oils in the amounts detailed below. Component parts are indicated in % amounts by volume, with the remainder of any solutions being made up with water.
Formulation 1 Orchid essences 5 by vol): Fitzroya cupressoide, Epidendrum chioneum, Mihonia phalaenopsis and Epidendrum Chioneum Secondary flower essences (7% by vol.): Am/ca montana, Prtmellandgaris, Matriciaria chamomilla, Zinnia, elegany, Rosa.spinosissima,Hibiscus, Rosa and Jepunbali Essential oils (0.2% by vol) Citrus reticulata, Citrus Sinensis, Pelargonium gravea, Litsea Cubebe, Aurantium Bergamia, geraniol, Limonene and Lavandtda angttytiforlia.
Formulation 2 Orchid essences 5 by vol): Fitzroya cupressoide, Epidendrum secundum, Oncidium altissimum and Oncidium sphacelatum Secondary flower essences (7% by vol.): Nehunbo nucifera, Rosa x, pruhoniciana, Echinocereus scheeri, Aloe vent, Prunella vulgarly, Jeptutawa, Paradise litastrum Essential oils (0.2% by vol) Rosa centifloria absolute, Jayminum officinale abs, Cananga adotvta, Pelargonium gravea and Citrus &nudist.
Formulation 3 Orchid essences (5 by vol): Fitzroya cupressoide, Angulo ado} ',Nil and Oncidium abortivum Secondary flower essences 7% by vol.): Rosa Moyesii, Strelitzia reginae, Passiflora bryontoides, Pilosocereus pachycladus, Prunella vulgarly, Aloe vera and Arnica montana Essential oils (0.2% by vol) Rosa centilloria abs, Cananga odorant, DCMCILS' Carota, Lavendula Angustitolia, Pelargonium gravea and Citrus paradist Formulation 4 according to the invention is a body oil formulation also made using conventional methods. The selected flower essences and essential oils in the amounts specified below were added drop wise to a base oil comprising Tahitian coconut oil with Gardenia flowers. Component parts are indicated in % amounts by volume, with the remainder of any solutions being made up with water.
Formulation 4 Orchid essences (10% by vol): Fitzroy' eupressoide, Angulo aclowesii, Oncidium abortivum, Cattleya warscewiczii and AMCIZ011aS Secondary flower essences (5% by vol.): Rosa Aloye,sii, Strelitzia reginae, Passiflora bryonioides. Pilosocereus pachycladus, Prurience vulgar/s. Aloe vera, Arnica montana, Rosa roxbourghii, Rosa moyesii, Orbeavariegata, Opzmtia cardiosperma and Lilium bulbiferum Essential oils (0.2% by vol) Rosa centifloria abs, Cananga ()donna, Pelargonium gravea, Citrus paradise and Cocosnucifera.
Formulations 5,6 and 7 according to the invention are a spritzer and toner for face and body formulation also made using conventional methods. The selected flower essences and essential oils in the amounts specified below were added drop wise to a base flower water comprising of hydrolats of essential oils. Component parts are indicated in % amounts by volume, with the remainder of any solutions being made up with water.
Formulation 5: Spritzer and Toner Flower waters (86% by vol): Hydrolats of Citrus Reliculata Orchid essences (5 by vol): Fitzroya cupressoide, Epidendrum chioneum, Millonia phalaenopsis and Epidendrum Chioneum Secondary flower essences 7% by vol.): Arnica montana, Prune 1/a vulgar/s. Matriciar a chamomilla, Zinnia, &Jewels, Rosa pinosissima,Hibiscus, Rosa andIepunbali Essential oils (0.2% by vol) Citrus retieulata, Citrus Sinensis, Pelargonium gravea, Litsea Cube he, Aurantium Bergamia, geraniol, Limonene and Lavandula angit.s1 ifbrlia.
Formulation 6: Spritzer and Toner Flower waters (86% by vol): Hydrolats of Rosa centifloria absolute Orchid essences (5 by vol): Fitzroy' eupressoide, Epidendrum seeundum, °iridium altissimum and °midterms phacelatuni Secondary flower essences 7% by vol.): Nelumbo nucifera, Rosa x, pruhoniciana, Echinocereusscheeri, Aloe vera, Prunella vulgaris, leptnawa, Paradise lilastmm Essential oils (0.2% by vol) Rosa centilloria absolute, Jasminum o. winale ab.s., Cananga adorata, Pelargonium gravea and Citrus Paradisi.
Formulation 7 Flower waters (86% by vol): Hydrolats of Lavandula angustilbrlia Orchid essences (5 by vol): Fitzroy( cupressoide, Angulo aclowesii and °within)/ abortivum Secondary flower essences (7V by vol.): Rosa Moyesii"Strehtzia reginae, Pass/flora bryonioide.s, Pilosocereus pachycladus, Prune//a 17/Vans, Aloe vera and Arnica montana Essential oils (0.2% by vol) Rosa centifloria abs, Cananga odorata, Dattczts Carol°, Lavendula Angustitolia, Pelargonium gravea and Citrus parodist Formulation 8: Cleansing / Detox Gel In a base of glycerin (vegetable), cera alba (beeswax) or candelilla wax, prunus amygdalus Aids (sweet almond) oil, coco-glucoside, oils of rosa damascena (rose) oil, citrus sinensis (orange) oil, citrus reticulata (mandarin) oil, pelgonium graveolens (geranium) oil, &sea cube ha (litsea) oil, cinnammomum camphora (ho leaf) oil, geraniol (rose oil), flower essence of epidendrum chionetim (sun orchid) citrus Il11101111111 (lemon blossom) Determination of the efficacy of the medicaments to reduce stress The stress-relief efficacy of the medicaments according to the present invention was determined as follows. Test patients were chosen who were suffering from stress caused, for example, through illness, or as a result of their lifestyle or due to a temporary period of stress.
Each one of Formulations 1 to 3 was formulated as an aqueous topical cream and was administered to the patient's face. Formulation 4 was administered to the whole body of the patient. Commercially available flower essence products, namely, "Bach Rescue Cream", available for example, from Boots Plc and "FES Self Heal Cream-, available for example, from Tesco Plc or Wholefoods, were used as comparative formulations and were administered to the patient in accordance with the packaging instructions. The patients were then monitored over a one-month period and at the end of this period they were asked to give their opinions and observations on the performance of the formulation(s) administered to them Comparative data for two known products is provided below.
Product Attributes Flower Therapy Boots® composition of the inventor Soft Orchid Body Botan cs Hydrating Lotion Lotion Appearance 7.08 4.46 Odour 6.62 3.54 Ease of Application 7.23 5.15 Ease of Absorbency 7.00 4.77 Absorbency time 6.00 4.15 Greasiness (lower score if greasier) 6.24 5.00 Irritation 5.00 5.00 Skin Feel (softness) 7.46 5.38 Skin Moisturisation 6.73 4.67 Product Attributes Flower Therapy Aveda® commercial composition of the equivalent inventor Soft Orchid Body Botanical Hydrating Lotion Lotion Appearance 7.08 6.77 Odour 6.62 6.38 Ease of Application 7.23 6.69 Ease of Absorbency 7.00 6.38 Absorbency time 6.00 6.00 Greasiness (lower score if greasier) 6.24 6.38 Irritation 5.00 5.00 Skin Feel (softness) 7.46 6.69 Skin Moisturisation 6.73 6.10 Results The compositions provide improved cosmetics properties, particularly as a body lotion. The present invention is preferably formulated for use as a body lotion. Each patient/user expressed the view that the formulations of the invention helped them to become less stressed in comparison to using no cream/body oil and the comparative commercially available products commercially available non-orchid essence containing flower products The improved cosmetics properties in better fulfilling user needs is considered a significant factor.
Conclusions
The medicament formulations according to the present invention that contain one or more orchid essences provide enhanced stress relief and mood enhancement compared with other commercially available non-orchid essence containing flower products.
In the present invention a plant extract is as obtained and utilised, the extract in all disclosures may be a plant stem cell extract and is preferably so but this is not mandatory in the disclosure. For clarity, in the present claims it is mandatory.

Claims (20)

  1. CLAIMS: 1 A composition suitable for reducing or alleviating stress, the composition comprising one or more plant stem cell extracts in combination with one or more flower essences.
  2. 2. The composition according to claim 1, wherein the one or more plant stem cell extracts are selected from monocot and dicot flowering plants, shrubs and trees.
  3. 3. The composition according to claim 1 or claim 2, wherein the one or more flower essences are selected from Acineta superba, Amazonas, Angulo aclowesii, Cctladenia lot ifol ia, Cat I leya warscewiczii, Cauleyatrianae, Chytroglossa aura/a, Cymbidium lowianum, Epidendrum chioneum, Epidendrum prismatocarpum, Epidendrum secundum, Fitzroya cupressoide, Hofmeister ellaru microscopica, Laeliocattleya anceps clam, Laehocattleya hybr., Miltonia phalaenopsis, Oncidium abortivum, Oncidittm altissimum, Oncidium incurvunr, Oncidirtm lcmcecinum, Oncidium,sphacelatum, Orchis mascula, Paphiopedilum hartysianztm, Paphiopedilum insigne, Stanhopecnvardii, Vander tricolor, Victoria aMCIZ011ial and combinations thereof
  4. 4. The composition according to claim 3, wherein the one or more flower essences are selected from Amazonas, Angulo aclowe,sii, Caladenia latifol ia, Conleya warscew iczii, Chytroglos.ser aurata, Epidendrum chioneum, Epidendrum secundum, Fitzroya cupressoide, Hofineister ellctru microscopica, Miltonia phalaenopsis, Oncidiztm abortivum, Oncidiutn,sphacelatum and combinations thereof 5. The composition according to any preceding claim, further comprising one or more secondary flower essences selected from Achillea miflefofluin, Aesculits hippocaylanum, A Ilium angulosum, All/urn ursinum, Aloe striata, Aloe vera, Anagallis arvensis, Anethum graveolens, Arnica montane', Artemisia arvensis, pereimis, Borago oflicinalis, BTOMUS ramosus, Canarina canariensis, Capsicum CIMMIMI, Caralluma russelliana, Celenchtla officinal is, Cereus peruviatms, Ceropegiofitsca, Chinencis viridnlora, bidus, Cistus allidus, Citrus limo'', Cleistocactus ritterei, Cleistocactus stausii, Cocos nucifera, Cucurbita pepo, Daunts carota, Dicentra spectabilis, Echinaecea putpurect, Echinocactus grusonii, Echinocereus scheeri, Echinopsis oxygotta, Echium vulgare, Echium-wildpretii, Epilobium (Inglis( libitum, Erica arborea, Eucalyptus globules, Euphorbia pulcherrima, Ferocactus schwarzii, Geranium perforaium, Ginkgo blink!, Helianthus annuus, Hibiscus rosa sinensis, Hibiscus, Hylocereus undatus, Hypericum perfbratum, Ipomea purpurea, Iris germanica, .leptjawa, Jepunbair, .lepuinmva, leptinmva, 1(9, Lavandula officinal's; LitilM1 bulbifertim, Alammi Hewitt rubrograndis, Matricaria chamoinilla, Menthe) pzdegium, Mimosa pudica, Monstera delic jaw, Athisa x paradisiacal, Myitillocachts geometrizans, Alyosolis sylvatica, Narcissus tazetta, Nelumbo nucifera, Ocimum basilicum, Oenothera ',kiln's, Opuntia cardiosperma, Opuntia defecta, Opzmtia cardio,sperma, Orbeavariegata, Paradisea Pass/flora buonioide,s, Pilosocereus pachydadus, P lumbago auriculata, Polygonum bistorta, Primula veris, pruhoniciana, Prune//a vu/gar's, Prunus ainygdahis, Ranunculus CICTE
  5. S, Rosa cat/Anti, Rosa majalis, Rosa moyesii, Rosa pinosissima, Rosa roxbourghii, Rosa rugosa -Sara van fleet", Rosa rugosa "Souvenir de philemoncochet", Rosa spinosissima, Rosa x pruhoniciana, Rosa, Rosmarnms officinal/s, RQ5 and RQ8, Rubits.fructicosus, Salty vitellina"Salvia officinalls Selenicereus grandiflorus, Seticereus icosagonus, Sonchus acaulis, Stapelia deshietiana, Stenocereus marginatus, Stopeha desmetiana, Strehtzia regime, Taraxaczt officinale, Trifolium pratense, Thssilago fitrara, Valerian() officinally, Verbascum thapstis, Vince) minor, Viola hirta, Viscum album, Zantedeschia aethiopica, Zea mays, Zinnia elegans and combinations thereof
  6. 6. The composition according to claim 5, wherein the one or more secondary flower essences are selected from Aloe vera, Arnica montana, Echinocereus scheeri, Hibiscus; Jepujawa"Iepunbali"Iepunawa, bulbiferum, Matriciaria chamomilla, Arehimbo micifera, Opzintia cardiasperma, Orbea variegata, Paradise hlastrum, Pass/flora bryonioides, P ilosocereus pachycladus, prithotticiana, Primal(' vulgar's, Rosa, Rosa moyesii, Rosa pinosissima, Rosa roxbourghii, Rosa xpruhoniciana"Strelitzia regime, Zinnia elegansand combinations thereof
  7. 7. The composition according to any preceding claim, further comprising one or more essential oils selected from Aluminum Bergamia, Buswellia sp., Cananga adorata, Cananga odorata, Chamaeme him, Citrus aurantifolia, Citrus aluminum, Citrus paradisi, Citrus reticulata, Citrus SitleSTISIS, Cocos nucifera, Cymbopogan martini, Cymbopogon citrates, Daucus carota, geraniol"Iasminum officinale abs, Lavandula angustiforha, Limonene, Litseacubebe, Melissa officinal/s, Pelargonium gravea, Ravensara aromatica, riganum, Rosa centifloria absolute, Santa/um album, Santa/urn spicanun and combinations thereof.
  8. 8. The composition according to any of claim 1 to claim 7, wherein the amount of the one or more flower essences is present in the range 0.5-15% by volume
  9. 9. The composition according to of claim 1 to claim 7, wherein the amount of the one or more flower essences is present in the range 2-10% by volume.
  10. 10. The composition according to any of claim 5 to claim 6, wherein the amount of the one or more secondary flower essences is present in the range 0.5-15% by volume.
  11. 11. The composition according to any of claim 5 to claim 6, wherein the amount of the one or more secondary flower essences is present in the range 2-10% by volume.
  12. 12. The composition according to claim 7, wherein the amount of the one or more essential oils is present in the range 0.05-5% by volume.
  13. 13. The composition according to claim 7, wherein the amount of the one or more essential oils is present in the range 0.05-3% by volume.
  14. 14. The composition according to claim 7, wherein the amount of the one or more essential oils is present in the range 0.1-1% by volume.
  15. 15. The composition according to any preceding claim, wherein the composition is an aqueous-based extract.
  16. 16. The composition according to any preceding claim, wherein the composition is a cream.
  17. 17 The composition according to any preceding claim, wherein the composition includes one or more optional berry extracts including, but not limited to, extracts of Maiqui berries.
  18. 18. The composition according to any preceding claim, wherein the composition comprises said Fitzroyct cupressoide in the defined plant extract.
  19. 19. The composition according to any preceding claim, wherein the composition consists of said Fitzroya cupressoide in the defined plant extract.
  20. 20. The composition according to claim 18 or 19 wherein the composition does not comprise stem cells, such a derived from the plant extract.
GB2118418.9A 2020-12-21 2021-12-17 Flower essence-containing medicaments Active GB2603634B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2020275.0A GB202020275D0 (en) 2020-12-21 2020-12-21 Flower essence-containg medicaments

Publications (2)

Publication Number Publication Date
GB2603634A true GB2603634A (en) 2022-08-10
GB2603634B GB2603634B (en) 2023-11-15

Family

ID=74221365

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2020275.0A Ceased GB202020275D0 (en) 2020-12-21 2020-12-21 Flower essence-containg medicaments
GB2118418.9A Active GB2603634B (en) 2020-12-21 2021-12-17 Flower essence-containing medicaments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2020275.0A Ceased GB202020275D0 (en) 2020-12-21 2020-12-21 Flower essence-containg medicaments

Country Status (1)

Country Link
GB (2) GB202020275D0 (en)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2409645B (en) * 2002-07-12 2006-03-01 Clare G Harvey Flower essence-containing medicaments
CN107638375A (en) * 2017-10-31 2018-01-30 广州赛莱拉干细胞科技股份有限公司 A kind of the spot removal and skin care liquid and preparation method of the extract of stem cell containing blueberry
CN107823118A (en) * 2017-12-07 2018-03-23 广州赛莱拉干细胞科技股份有限公司 A kind of skin care item of the smoothing wrinkle of the extract of stem cell containing azalea
CN107961210A (en) * 2017-12-12 2018-04-27 广州赛莱拉干细胞科技股份有限公司 A kind of whitening spot-removing skin care item containing sealwort stem cell extract
CN107982205A (en) * 2017-12-15 2018-05-04 广州赛莱拉干细胞科技股份有限公司 A kind of composition of anti-acne of the extract of stem cell containing rhizoma Gastrodiae and application
CN108815100A (en) * 2018-08-09 2018-11-16 广州暨南生物医药研究开发基地有限公司 Bacterio static itching-relieving skin care item and preparation method thereof containing folium artemisiae argyi stem cell extract
CN110935014A (en) * 2018-09-25 2020-03-31 元穗生物科技(上海)有限公司 Special natural herbal oral skin mucosa disinfection spray for children
CN110946818A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal skin mucosa disinfectant special for private parts of men
CN110946816A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal ulcer-removing oral and oral cavity spray
CN110946817A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal skin mucosa disinfectant special for private parts of women
CN110946159A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Plant essence biological compound clothing mildew sweat odor removing agent
CN111821428A (en) * 2019-04-15 2020-10-27 青岛博文汇智文化科技有限公司 Novel female antibacterial care solution
CN112915186A (en) * 2021-02-04 2021-06-08 伊比特(广州)生物科技有限公司 Vagina contracting liquid and preparation method thereof
CN113616774A (en) * 2021-09-10 2021-11-09 山东丽达生物科技集团有限公司 Plant stem cell-containing antibacterial composition, maintenance antibacterial liquid and preparation method thereof

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2409645B (en) * 2002-07-12 2006-03-01 Clare G Harvey Flower essence-containing medicaments
CN107638375A (en) * 2017-10-31 2018-01-30 广州赛莱拉干细胞科技股份有限公司 A kind of the spot removal and skin care liquid and preparation method of the extract of stem cell containing blueberry
CN107823118A (en) * 2017-12-07 2018-03-23 广州赛莱拉干细胞科技股份有限公司 A kind of skin care item of the smoothing wrinkle of the extract of stem cell containing azalea
CN107961210A (en) * 2017-12-12 2018-04-27 广州赛莱拉干细胞科技股份有限公司 A kind of whitening spot-removing skin care item containing sealwort stem cell extract
CN107982205A (en) * 2017-12-15 2018-05-04 广州赛莱拉干细胞科技股份有限公司 A kind of composition of anti-acne of the extract of stem cell containing rhizoma Gastrodiae and application
CN108815100A (en) * 2018-08-09 2018-11-16 广州暨南生物医药研究开发基地有限公司 Bacterio static itching-relieving skin care item and preparation method thereof containing folium artemisiae argyi stem cell extract
CN110935014A (en) * 2018-09-25 2020-03-31 元穗生物科技(上海)有限公司 Special natural herbal oral skin mucosa disinfection spray for children
CN110946818A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal skin mucosa disinfectant special for private parts of men
CN110946816A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal ulcer-removing oral and oral cavity spray
CN110946817A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Natural herbal skin mucosa disinfectant special for private parts of women
CN110946159A (en) * 2018-09-25 2020-04-03 元穗生物科技(上海)有限公司 Plant essence biological compound clothing mildew sweat odor removing agent
CN111821428A (en) * 2019-04-15 2020-10-27 青岛博文汇智文化科技有限公司 Novel female antibacterial care solution
CN112915186A (en) * 2021-02-04 2021-06-08 伊比特(广州)生物科技有限公司 Vagina contracting liquid and preparation method thereof
CN113616774A (en) * 2021-09-10 2021-11-09 山东丽达生物科技集团有限公司 Plant stem cell-containing antibacterial composition, maintenance antibacterial liquid and preparation method thereof

Also Published As

Publication number Publication date
GB2603634B (en) 2023-11-15
GB202020275D0 (en) 2021-02-03

Similar Documents

Publication Publication Date Title
Rose The aromatherapy book: applications and inhalations
KR101478945B1 (en) Shampoo composition containing native plant extracts and natural oriental material extracts
US11191712B2 (en) Skin treatment compositions, masks, and related methods
Mindell Dr. Earl Mindell's Herb Bible: Fight Depression and Anxiety, Improve Your Sex Life, Prevent Illness, and Heal Faster—the All-Natural Way
US20060120990A1 (en) Composition for treating hair and scalp and method for preparing same
KR20180083719A (en) A aromatic composition having anti-stress and fatigue relaxing, and a cosmetic composition containing the same
Goswami et al. White sandal (Santalum album L.), a precious medicinal and timber yielding plant: a short review.
GB2381195A (en) Orchid essence containing medicaments for the treatment of stress
CN111643610A (en) Plant composite liquid and preparation method and application thereof
CN102335342A (en) Chinese medicinal composition for treating chloasma, preparation method and application thereof
KR20190036628A (en) Beauty composition for renewing skin comprising frankincense, myrrh and gold powder, beauty product including the same, and beauty product manufacturing method
US20120305415A1 (en) Cosmetic product
GB2603634A (en) Flower essence-containing medicaments
US20240050503A1 (en) Flower essence-containing medicaments
CN107362244A (en) A kind of Eradicates removes the Chinese medical extract and its external preparation of red blood trace on face
CN106389286A (en) Formula and process for supercritical propolis tincture with facial beautifying and antibacterial actions
RU2414885C1 (en) Cosmetic preparation based on phitoestrogen biocomplex
CN108403603A (en) A kind of cherry kaempferia galanga beauty treatment and eliminating spot natural traditional Chinese medicine face mask cream and preparation method thereof
Talreja et al. An In Depth Exploration of Ginkgo Biloba: A Review
Tierra Healing with the Herbs of Life: Hundreds of Herbal Remedies, Therapies, and Preparations
Anjum et al. TRADITIONAL MUKHALEPA: ANCIENT WISDOM OF ENHANCING SKIN RADIANCE AND BEAUTY
Fite et al. Essential Oils for Healing: Over 400 All-Natural Recipes for Everyday Ailments
Trak et al. Skin Care Secrets from Herbal World
CN104922642B (en) For treating bald external medicine composition
TWI352602B (en) Use of active extracts to improve the appearance o